117 related articles for article (PubMed ID: 8884883)
1. Regional differences in cerebral noradrenaline turnover in mice withdrawn from repeated morphine treatment and tolerance to the effects of acute morphine.
Airio J; Attila M; Ahtee L
Pharmacol Toxicol; 1995 Sep; 77(3):196-203. PubMed ID: 8884883
[TBL] [Abstract][Full Text] [Related]
2. Acceleration of cerebral noradrenaline turnover after morphine withdrawal and its retardation by acute morphine administration in rats.
Attila LM; Ahtee L
Naunyn Schmiedebergs Arch Pharmacol; 1984 Sep; 327(3):193-200. PubMed ID: 6541758
[TBL] [Abstract][Full Text] [Related]
3. Cerebral dopamine and noradrenaline turnover and effects of morphine test dose in rats withdrawn from 20 days' morphine treatment.
Attila LM; Ahtee L
Med Biol; 1983; 61(5):249-257. PubMed ID: 6686987
[TBL] [Abstract][Full Text] [Related]
4. Effects of acute morphine administration on noradrenaline turnover and metabolism in various brain parts of control and handled rats.
Attila LM
Pharmacol Toxicol; 1989 Feb; 64(2):202-9. PubMed ID: 2755921
[TBL] [Abstract][Full Text] [Related]
5. The involvement of noradrenergic transmission in the morphine-induced locomotor hyperactivity in mice withdrawn from repeated morphine treatment.
Airio J; Ahtee L
Br J Pharmacol; 1999 Apr; 126(7):1609-19. PubMed ID: 10323593
[TBL] [Abstract][Full Text] [Related]
6. Cerebral catecholamine depletion in mice withdrawn from repeated morphine treatment and development of tolerance to the enhancing effect of morphine on noradrenaline depletion.
Etemadzadeh E
J Pharmacol Exp Ther; 1993 Aug; 266(2):749-55. PubMed ID: 8355206
[TBL] [Abstract][Full Text] [Related]
7. Differences in the effects of morphine on the alpha-methyl-p-tyrosine-induced depletion of dopamine and noradrenaline in various areas of the mouse brain.
Martti L; Attila J; Etemadzadeh E; Ahtee L
Pharmacol Toxicol; 1987 Jul; 61(1):26-32. PubMed ID: 3628178
[TBL] [Abstract][Full Text] [Related]
8. Retardation of cerebral dopamine turnover after morphine withdrawal and its enhanced acceleration by acute morphine administration in rats.
Attila LM; Ahtee L
Naunyn Schmiedebergs Arch Pharmacol; 1984 Sep; 327(3):201-7. PubMed ID: 6541759
[TBL] [Abstract][Full Text] [Related]
9. Cerebral dopamine and noradrenaline in mice withdrawn from repeated morphine treatment and development of tolerance to a test dose of morphine.
Etemadzadeh E
Gen Pharmacol; 1994 Jul; 25(4):623-9. PubMed ID: 7958720
[TBL] [Abstract][Full Text] [Related]
10. Role of cerebral dopamine and noradrenaline in the morphine-induced locomotor sensitisation in mice.
Airio J; Ahtee L
Pharmacol Biochem Behav; 1997 Oct; 58(2):379-86. PubMed ID: 9300596
[TBL] [Abstract][Full Text] [Related]
11. Withdrawal from repeated morphine sensitizes mice to the striatal dopamine release enhancing effect of acute morphine.
Airio J; Attila M; Leikola-Pelho T; Ahtee L
Naunyn Schmiedebergs Arch Pharmacol; 1994 Nov; 350(5):548-54. PubMed ID: 7870194
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of protein kinase C but not protein kinase A attenuates morphine withdrawal excitation of rat hypothalamus-pituitary-adrenal axis.
Cerezo M; Laorden ML; Milanés MV
Eur J Pharmacol; 2002 Sep; 452(1):57-66. PubMed ID: 12323385
[TBL] [Abstract][Full Text] [Related]
13. Effects of U-50,488H and U-50,488H withdrawal on catecholaminergic neurons of the rat hypothalamus.
Laorden ML; Milanés MV
Life Sci; 2000 Jan; 66(9):803-15. PubMed ID: 10698355
[TBL] [Abstract][Full Text] [Related]
14. Catecholamine utilization in distinct mouse brain nuclei during acute morphine treatment, morphine tolerance and withdrawal syndrome.
Kovács GL; Acsai L; Tihanyi A; Telegdy G
Eur J Pharmacol; 1983 Sep; 93(3-4):149-58. PubMed ID: 6685650
[TBL] [Abstract][Full Text] [Related]
15. Different acute effects of the tyrosine hydroxylase inhibitors alpha-methyl-p-tyrosine and 3-iodo-L-tyrosine on hypothalamic noradrenaline activity and adrenocorticotrophin release in the rat.
Smythe GA; Bradshaw JE
Aust J Biol Sci; 1983; 36(5-6):519-23. PubMed ID: 6144300
[TBL] [Abstract][Full Text] [Related]
16. Changes in brain monoamine metabolism during withdrawal from chronic oral self-administration of morphine and in response to a morphine challenge in the withdrawn state.
Ahtee L; Attila LM; Carlson KR; Haikala H
J Pharmacol Exp Ther; 1989 Apr; 249(1):303-10. PubMed ID: 2468763
[TBL] [Abstract][Full Text] [Related]
17. Effects of corticotropin-releasing factor receptor-1 antagonists on the brain stress system responses to morphine withdrawal.
Navarro-Zaragoza J; Núñez C; Laorden ML; Milanés MV
Mol Pharmacol; 2010 May; 77(5):864-73. PubMed ID: 20159948
[TBL] [Abstract][Full Text] [Related]
18. Co-release of noradrenaline and dopamine in the prefrontal cortex after acute morphine and during morphine withdrawal.
Devoto P; Flore G; Pira L; Diana M; Gessa GL
Psychopharmacology (Berl); 2002 Mar; 160(2):220-4. PubMed ID: 11875641
[TBL] [Abstract][Full Text] [Related]
19. Differential involvement of 3', 5'-cyclic adenosine monophosphate-dependent protein kinase in regulation of Fos and tyrosine hydroxylase expression in the heart after naloxone induced morphine withdrawal.
Almela P; Cerezo M; González-Cuello A; Milanés MV; Laorden ML
Naunyn Schmiedebergs Arch Pharmacol; 2007 Jan; 374(4):293-303. PubMed ID: 17216288
[TBL] [Abstract][Full Text] [Related]
20. Noradrenaline synthesis from L-DOPA in rodents and its relationship to motor activity.
Dolphin A; Jenner P; Marsden CD
Pharmacol Biochem Behav; 1976 Oct; 5(4):431-9. PubMed ID: 1005491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
